Back
2007N-0123: Amlodipine Abbreviated New Drug Application Approvals
C3 Mutual Pharmaceutical Co. Inc.
Comment
Exhibit A Federal Rules of Appellate Procedure Copyrighted
Exhibit B March 25, 2007 Letter to FDA from Covington & Burling representing Pfizer
Exhibit C - Guidance for Industry, ANDA Approvals, and 180-Day Exclusivity Under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act, March 2000
Page last updated April 5, 2007 kk Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA FDA/Dockets Management